Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease

Acta Neurologica Scandinavica

Volumn 124, Issue 3, 2011, Pages 211-214

  Evidente, V G H ^a   Premkumar, A P ^a   Adler, C H ^a   Caviness, J N ^a   Driver Dunckley, E ^a   Lyons, M K ^b  

^a Department of Neurology ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

DBS; Deep brain stimulation; GPi; Parkinson's disease; STN

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; GLOBUS PALLIDUS; HUMAN; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; GLOBUS PALLIDUS; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MIDDLE AGED; NEURAL PATHWAYS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SUBTHALAMIC NUCLEUS; TIME; TREATMENT OUTCOME;

EID: 79961206372     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01455.x     Document Type: Article

References (12)

1. Deep-Brain Stimulation For Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
2. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999;45:1375-82.
3. Krack P, Pollak P, Limousin P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121(Pt 3):451-7.
4. Krause M, Fogel W, Heck A et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001;70:464-70.
5. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2001;56:548-51.
6. Follet KA, Weaver FM, Stern M et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-91.
7. Okun MS, Fernandez HH, Wu SS et al. Cognition and mood in Parkinson's Disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009;65:586-95.
8. Videnovic A, Metman LV. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord 2008;23: 343-9.
9. Vitek JL. Deep brain stimulation for Parkinson's disease. A critical re-evaluation of STN versus GPi DBS. Stereotact Funct Neurosurg 2002;78:119-31.
10. Follett KA. Comparison of pallidal and subthalamic deep brain stimulation for the treatment of levodopa-induced dyskinesias. Neurosurg Focus 2004;17:14-9.
11. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005;62:554-60.
12. Minguez-Castellanos A, Escamilla-Sevilla F, Katati MJ et al. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias? J Neurol Neurosurg Psychiatry 2005;76:34-9.